Welkom bij Scalda & Bohn Stafleu van Loghum
Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.
01-10-2012 | Klinische Les
Mild Cognitive Impairment
Auteurs: J. H. Verwoerd, dr. F. U. S. Mattace-Raso
Gepubliceerd in: Huisarts en wetenschap | Uitgave 10/2012
Log in om toegang te krijgenshare
DELEN
Deel dit onderdeel of sectie (kopieer de link)
-
Optie A:
-
Optie B:Deel de link per e-mail
Samenvatting
Verwoerd JH, Mattace-Raso FUS. Mild Cognitive Impairment. Huisarts Wet 2012;55(10):464-7.
Mild Cognitive Impairment (MCI) is een heterogeen ziektebeeld dat geriaters en neurologen de laatste jaren geregeld diagnosticeren en waarnaar men veel onderzoek doet. MCI betreft een lichte cognitieve achteruitgang die erger is dan men op basis van leeftijd mag verwachten, maar die niet aan de diagnose dementie voldoet. Men stelt de diagnose op basis van anamnese en heteroanamnese, bij voorkeur aangevuld met een objectieve test om de cognitieve status in kaart te brengen. MCI is een belangrijke risicofactor voor het ontwikkelen van dementie; jaarlijks krijgt 5-15% van de patiënten met MCI dementie. Er zijn geen therapeutische opties voor MCI. Wel is het belangrijk eventuele somatische factoren te behandelen. Vooralsnog lijkt het vooral voor de huisarts belangrijk om de achtergrond van een gediagnosticeerde MCI of aangegeven lichte cognitieve problemen te kennen, en patiënten en hun naasten te begeleiden. Het stellen van de diagnose MCI door de huisarts zelf lijkt hierbij geen meerwaarde te hebben.
Log in om toegang te krijgen
Literatuur
1.
go back to reference Petersen RC. Clinical practice. Mild cognitive impairment. NEJM 2011;364:2227–34.PubMedCrossRef
Petersen RC. Clinical practice. Mild cognitive impairment. NEJM 2011;364:2227–34.PubMedCrossRef
2.
go back to reference Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–8.PubMedCrossRef
Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–8.PubMedCrossRef
3.
go back to reference Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133–42.PubMedCrossRef
Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133–42.PubMedCrossRef
4.
go back to reference Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240–6.PubMedCrossRef
Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240–6.PubMedCrossRef
5.
go back to reference Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183–94.PubMedCrossRef
Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183–94.PubMedCrossRef
6.
go back to reference Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397–405.PubMedCrossRef
Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397–405.PubMedCrossRef
7.
go back to reference Werner P, Korczyn AD. Mild cognitive impairment: conceptual, assessment, ethical, and social issues. Clin Interv Aging 2008;3:413–20.PubMed
Werner P, Korczyn AD. Mild cognitive impairment: conceptual, assessment, ethical, and social issues. Clin Interv Aging 2008;3:413–20.PubMed
8.
go back to reference Gauthier S, Touchon J. Mild cognitive impairment is not a clinical entity and should not be treated. Arch Neurol 2005;62:1164–6; discussion 1167.
Gauthier S, Touchon J. Mild cognitive impairment is not a clinical entity and should not be treated. Arch Neurol 2005;62:1164–6; discussion 1167.
9.
go back to reference Whitehouse P, Brodaty H. Mild cognitive impairment. Lancet 2006;367:1979.PubMedCrossRef
Whitehouse P, Brodaty H. Mild cognitive impairment. Lancet 2006;367:1979.PubMedCrossRef
10.
go back to reference Whitehouse PJ. Mild cognitive impairment - a confused concept? Nat Clin Pract Neurol 2007;3:62–3.PubMedCrossRef
Whitehouse PJ. Mild cognitive impairment - a confused concept? Nat Clin Pract Neurol 2007;3:62–3.PubMedCrossRef
11.
go back to reference Maggini M, Vanacore N, Raschetti R. Cholinesterase inhibitors: drugs look ing for a disease? PLoS Med 2006;3:e140.PubMedCrossRef
Maggini M, Vanacore N, Raschetti R. Cholinesterase inhibitors: drugs look ing for a disease? PLoS Med 2006;3:e140.PubMedCrossRef
12.
go back to reference Ganguli M, Blacker D, Blazer DG, Grant I, Jeste DV, Paulsen JS, et al. Classification of neurocognitive disorders in DSM-5: a work in progress. Am J Geriatr Psychiatry 2011;19:205–10.PubMedCrossRef
Ganguli M, Blacker D, Blazer DG, Grant I, Jeste DV, Paulsen JS, et al. Classification of neurocognitive disorders in DSM-5: a work in progress. Am J Geriatr Psychiatry 2011;19:205–10.PubMedCrossRef
13.
go back to reference Ward A, Arrighi HM, Michels S, Cedarbaum JM. Mild cognitive impairment: Disparity of incidence and prevalence estimates. Alzheimers Dement 2012;8:14–21.PubMedCrossRef
Ward A, Arrighi HM, Michels S, Cedarbaum JM. Mild cognitive impairment: Disparity of incidence and prevalence estimates. Alzheimers Dement 2012;8:14–21.PubMedCrossRef
14.
go back to reference Moll van Charante E, Perry M, Vernooij-Dassen MJFJ, Boswijk DFR, Stoffels J, Achthoven L, et al. NHG-Standaard Dementie (derde herziening). Huisarts Wet 2012;55:306–17.
Moll van Charante E, Perry M, Vernooij-Dassen MJFJ, Boswijk DFR, Stoffels J, Achthoven L, et al. NHG-Standaard Dementie (derde herziening). Huisarts Wet 2012;55:306–17.
15.
go back to reference Mitchell AJ. A meta-analysis of the accuracy of the Mini-Mental State Exam ination in the detection of dementia and mild cognitive impairment. J Psychiatr Res 2009;43:411–31.PubMedCrossRef
Mitchell AJ. A meta-analysis of the accuracy of the Mini-Mental State Exam ination in the detection of dementia and mild cognitive impairment. J Psychiatr Res 2009;43:411–31.PubMedCrossRef
16.
go back to reference Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695–9.PubMedCrossRef
Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695–9.PubMedCrossRef
17.
go back to reference Tang-Wai DF, Knopman DS, Geda YE, Edland SD, Smith GE, Ivnik RJ, et al. Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment. Arch Neurol 2003;60:1777–81.PubMedCrossRef
Tang-Wai DF, Knopman DS, Geda YE, Edland SD, Smith GE, Ivnik RJ, et al. Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment. Arch Neurol 2003;60:1777–81.PubMedCrossRef
18.
go back to reference Freitas S, Simões MR, Alves L, Santana I. Montreal Cognitive Assessment: Validation Study for Mild Cognitive Impairment and Alzheimer Disease. Alzheimer Dis Assoc Disord 2011 Dec 20 [Epub ahead of print].
Freitas S, Simões MR, Alves L, Santana I. Montreal Cognitive Assessment: Validation Study for Mild Cognitive Impairment and Alzheimer Disease. Alzheimer Dis Assoc Disord 2011 Dec 20 [Epub ahead of print].
19.
go back to reference Muangpaisan W, Petcharat C, Srinonprasert V. Prevalence of potentially reversible conditions in dementia and mild cognitive impairment in a ger iatric clinic. Geriatr Gerontol Int 2012;12:59–64.PubMedCrossRef
Muangpaisan W, Petcharat C, Srinonprasert V. Prevalence of potentially reversible conditions in dementia and mild cognitive impairment in a ger iatric clinic. Geriatr Gerontol Int 2012;12:59–64.PubMedCrossRef
20.
go back to reference Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009;119:252–65.PubMedCrossRef
Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009;119:252–65.PubMedCrossRef
21.
go back to reference Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al. Prevalence of cognitive impairment without dementia in the United States. Ann Int Med 2008;148:427–34.PubMed
Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al. Prevalence of cognitive impairment without dementia in the United States. Ann Int Med 2008;148:427–34.PubMed
22.
go back to reference Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol 2009;66:1151–7.PubMedCrossRef
Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol 2009;66:1151–7.PubMedCrossRef
23.
go back to reference Manly JJ, Tang MX, Schupf N, Stern Y, Vonsattel JP, Mayeux R. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol 2008;63:494–506.PubMedCrossRef
Manly JJ, Tang MX, Schupf N, Stern Y, Vonsattel JP, Mayeux R. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol 2008;63:494–506.PubMedCrossRef
24.
go back to reference Matthews FE, Stephan BC, McKeith IG, Bond J, Brayne C. Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J Am Geriatr Soc 2008;56:1424–33.PubMedCrossRef
Matthews FE, Stephan BC, McKeith IG, Bond J, Brayne C. Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree? J Am Geriatr Soc 2008;56:1424–33.PubMedCrossRef
25.
go back to reference Mitchell AJ, Shiri-Feshki M. Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis. J Neurol Neurosurg Psychiatry 2008;79:1386–91.PubMedCrossRef
Mitchell AJ, Shiri-Feshki M. Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis. J Neurol Neurosurg Psychiatry 2008;79:1386–91.PubMedCrossRef
26.
go back to reference Dickerson BC, Sperling RA, Hyman BT, Albert MS, Blacker D. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry 2007;64:1443–50.PubMedCrossRef
Dickerson BC, Sperling RA, Hyman BT, Albert MS, Blacker D. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry 2007;64:1443–50.PubMedCrossRef
27.
go back to reference Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 2007;68:1588–95.PubMedCrossRef
Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 2007;68:1588–95.PubMedCrossRef
28.
go back to reference Visser PJ, Kester A, Jolles J, Verhey F. Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology 2006;67:1201–7.PubMedCrossRef
Visser PJ, Kester A, Jolles J, Verhey F. Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology 2006;67:1201–7.PubMedCrossRef
29.
go back to reference Kryscio RJ, Schmitt FA, Salazar JC, Mendiondo MS, Markesbery WR. Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology 2006;66:828–32.PubMedCrossRef
Kryscio RJ, Schmitt FA, Salazar JC, Mendiondo MS, Markesbery WR. Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology 2006;66:828–32.PubMedCrossRef
30.
go back to reference Tyas SL, Salazar JC, Snowdon DA, Desrosiers MF, Riley KP, Mendiondo MS, et al. Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. Am J Epidemiol 2007;165:1231–8.PubMedCrossRef
Tyas SL, Salazar JC, Snowdon DA, Desrosiers MF, Riley KP, Mendiondo MS, et al. Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. Am J Epidemiol 2007;165:1231–8.PubMedCrossRef
31.
go back to reference Di Carlo A, Lamassa M, Baldereschi M, Inzitari M, Scafato E, Farchi G, et al. CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology 2007;68:1909–16.PubMedCrossRef
Di Carlo A, Lamassa M, Baldereschi M, Inzitari M, Scafato E, Farchi G, et al. CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology 2007;68:1909–16.PubMedCrossRef
32.
go back to reference Li J, Wang YJ, Zhang M, Xu ZQ, Gao CY, Fang CQ, et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology 2011;76:1485–91.PubMedCrossRef
Li J, Wang YJ, Zhang M, Xu ZQ, Gao CY, Fang CQ, et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology 2011;76:1485–91.PubMedCrossRef
33.
go back to reference Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 2008;CD004514.
Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 2008;CD004514.
34.
go back to reference Loy C, Schneider L. Galantamine for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev 2006;CD001747.
Loy C, Schneider L. Galantamine for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev 2006;CD001747.
35.
go back to reference Isaac MG, Quinn R, Tabet N. Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev 2008;CD002854.
Isaac MG, Quinn R, Tabet N. Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev 2008;CD002854.
36.
go back to reference Birks J, Flicker L. Donepezil for mild cognitive impairment. Cochrane Database Syst Rev 2006;CD006104.
Birks J, Flicker L. Donepezil for mild cognitive impairment. Cochrane Database Syst Rev 2006;CD006104.
37.
go back to reference Martin M, Clare L, Altgassen AM, Cameron MH, Zehnder F. Cognitionbased interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev 2011;CD006220.
Martin M, Clare L, Altgassen AM, Cameron MH, Zehnder F. Cognitionbased interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev 2011;CD006220.
38.
go back to reference Joosten-Weyn Banningh LW, Prins JB, Vernooij-Dassen MJ, Wijnen HH, Olde Rikkert MG, Kessels RP. Group therapy for patients with mild cognitive impairment and their significant others: results of a waiting-list controlled trial. Gerontology 2011;57:444–54.PubMed
Joosten-Weyn Banningh LW, Prins JB, Vernooij-Dassen MJ, Wijnen HH, Olde Rikkert MG, Kessels RP. Group therapy for patients with mild cognitive impairment and their significant others: results of a waiting-list controlled trial. Gerontology 2011;57:444–54.PubMed
39.
go back to reference Ahlskog JE, Geda YE, Graff-Radford NR, Petersen RC. Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin Proc 2011;86:876–84.PubMedCrossRef
Ahlskog JE, Geda YE, Graff-Radford NR, Petersen RC. Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging. Mayo Clin Proc 2011;86:876–84.PubMedCrossRef
40.
go back to reference Lautenschlager NT, Cox KL, Flicker L, Foster JK, Van Bockxmeer FM, Xiao J, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008;300:1027–37.PubMedCrossRef
Lautenschlager NT, Cox KL, Flicker L, Foster JK, Van Bockxmeer FM, Xiao J, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008;300:1027–37.PubMedCrossRef
41.
go back to reference Jansen APD, Van Hout HPJ, Nijpels G, Rijmen F, Dröes RM, Pot AM, et al. Casemanagement bij beginnende dementie. Huisarts Wet 2011;55:58–63.CrossRef
Jansen APD, Van Hout HPJ, Nijpels G, Rijmen F, Dröes RM, Pot AM, et al. Casemanagement bij beginnende dementie. Huisarts Wet 2011;55:58–63.CrossRef
42.
go back to reference Chertkow H, Massoud F, Nasreddine Z, Belleville S, Joanette Y, Bocti C, et al. Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ 2008;178:1273–85.PubMedCrossRef
Chertkow H, Massoud F, Nasreddine Z, Belleville S, Joanette Y, Bocti C, et al. Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ 2008;178:1273–85.PubMedCrossRef
43.
go back to reference Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006;332:455–9.
Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006;332:455–9.
44.
go back to reference Iliffe S, Manthorpe J, Eden A. Sooner or later? Issues in the early diagnosis of dementia in general practice: a qualitative study. Fam Pract 2003;20:376–81.PubMedCrossRef
Iliffe S, Manthorpe J, Eden A. Sooner or later? Issues in the early diagnosis of dementia in general practice: a qualitative study. Fam Pract 2003;20:376–81.PubMedCrossRef
45.
go back to reference Joosten-Weyn Banningh L, Vernooij-Dassen M, Rikkert MO, Teunisse JP. Mild cognitive impairment: coping with an uncertain label. Int J Geriatr Psychiatry 2008;23:148–54.PubMedCrossRef
Joosten-Weyn Banningh L, Vernooij-Dassen M, Rikkert MO, Teunisse JP. Mild cognitive impairment: coping with an uncertain label. Int J Geriatr Psychiatry 2008;23:148–54.PubMedCrossRef
Metagegevens
- Titel
- Mild Cognitive Impairment
- Auteurs
-
J. H. Verwoerd
dr. F. U. S. Mattace-Raso
- Publicatiedatum
- 01-10-2012
- Uitgeverij
- Bohn Stafleu van Loghum
- Gepubliceerd in
-
Huisarts en wetenschap
/ Uitgave 10/2012
Print ISSN: 0018-7070
Elektronisch ISSN: 1876-5912 - DOI
- https://doi.org/10.1007/s12445-012-0228-y